S29—1 NameThis Standard is Australia New Zealand Food Standards Code – Schedule 29 – Special purpose foods.Note Commencement:This Standard commences on 1 March 2016, being the date specified as the commencement date in notices in the Gazette and the New Zealand Gazette under section 92 of the Food Standards Australia New Zealand Act 1991 (Cth). See also section 93 of that Act.S29—2 Infant formula products—calculation of energy content(1) For paragraph 2.9.1—4(2)(a), the energy content of infant formula product must be calculated using:(a) the energy contributions of the following *components only:(i) fat; and(ii) protein; and(iii) carbohydrate; and(b) the relevant energy factors set out in section S11—2.(2) The energy content of an infant formula product must be expressed in kilojoules.S29—2A Infant formula products—calculation of protein contentFor paragraph 2.9.1—4(2)(b), the protein content of infant formula product must be calculated by multiplying the nitrogen content of the product by a nitrogen-to-protein conversion factor of 6.25.S29—2B Infant formula products—calculation of vitamin A contentFor paragraph 2.9.1—4(2)(c), the vitamin A content of infant formula products must be calculated using only the retinol forms of vitamin A prescribed in Column 1 of Table S29—23. S29—3 Infant formula products—L-amino acids that must be presentFor subsection 2.9.1—6(5) and section 2.9.1—33, the table is:L-amino acids that must be present in infant formula productsL-amino acid | Minimum amount per 100 kJCysteine | 9 mgHistidine | 10 mgIsoleucine | 22 mgLeucine | 40 mgLysine | 27 mgMethionine | 6 mgPhenylalanine | 19 mgThreonine | 18 mgTryptophan | 8 mgTyrosine | 18 mgValine | 22 mgS29—4 Infant formula products—limits on fatty acids For paragraphs 2.9.1—7(1)(g) and 2.9.1—34(1)(g), the table is:Limits on fatty acids that may be present in infant formula productsColumn 1 | Column 2Substance | Maximum amountper 100 kJDocosahexaenoic acid | 12 mgTotal trans fatty acids | Not more than 4% of the total fatty acidsErucic acid (22:1) | Not more than 1% of the total fatty acidsS29—5 Vitamins, minerals, electrolytes and other substances required in infant formula and special medical purpose product for infantsFor sections 2.9.1—7(2)(b)(i), 2.9.1—8(1), 2.9.1—34(2)(b) and 2.9.1—36(1), the table is:Vitamins, minerals, electrolytes and other nutritive substances required in infant formula and special medical purpose product for infantsColumn 1 | Column 2 | Column 3 | Column 4Substance | Minimum amountper 100 kJ | Maximum amountper 100 kJ | Guidance upper levelper 100 kJ (see Note)VitaminsVitamin A | 14 μg RE | 43 μg REVitamin D | 0.24 μg | 0.63 μgVitamin C | 1.7 mg | 17 mgThiamin | 10 μg | 72 µgRiboflavin | 14.3 μg | 120 µgNiacin | 72 μg | 359 µgVitamin B6 | 8 μg | 42 µgFolic acid | 2.4 μg | 12 µgPantothenic acid | 96 μg | 478 µgVitamin B12 | 0.02 μg | 0.36 µgBiotin | 0.24 μg | 2.4 µgVitamin E | 0.14 mg α-TE | 1.2 mg α-TEVitamin K | 0.24 μg | 6 µgMineralsCalcium | 12 mg | 35 mgPhosphorus | 6 mg | 24 mgMagnesium | 1.2 mg | 3.6 mgIron | 0.14 mg | 0.48 mgIodine | 2.4 μg | 14 µgCopper | 8 μg | 29 µgZinc | 0.12 mg | 0.36 mgManganese | 0.24 μg | 24 μgSelenium | 0.48 μg | 2.2 µgElectrolytesChloride | 12 mg | 38 mgSodium | 4.8 mg | 14 mgPotassium | 14 mg | 43 mgOther essential substancesCholine | 1.7 mg | 12 mgL-carnitine | 0.3 mg | 0.8 mgInositol | 1 mg | 10 mgNote It is recommended that infant formula and a special medical purpose product for infants contain a substance listed in Column 1 of the table in an amount that is not more than the amount (if any) specified for that substance in Column 4 of the table. The amounts specified in Column 4 are Guidance Upper Levels and are recommended upper levels for nutrients which pose no significant risks on the basis of current scientific knowledge. These levels are values derived on the basis of meeting nutritional requirements of infants and an established history of apparent safe use. These Guidance Upper Levels should not be exceeded unless higher nutrient levels cannot be avoided due to high or variable contents in constituents of infant formulas or special medical purpose product for infants; or due to technological reasons.S29—6 Vitamins, minerals and electrolytes required in follow-on formulaFor subparagraph 2.9.1—7(2)(b)(ii) and subsection 2.9.1—8(2), the table is:Vitamins, minerals and electrolytes required in follow-on formulaColumn 1 | Column 2 | Column 3 | Column 4Vitamin, mineral or electrolyte | Minimum amountper 100 kJ | Maximum amountper 100 kJ | Guidance upper levelper 100 kJ (see Note)VitaminsVitamin A | 14 μg RE | 43 μg REVitamin D | 0.24 μg | 0.72 μgVitamin C | 1.7 mg | 17 mgThiamin | 10 μg | 72 µgRiboflavin | 14.3 μg | 120 µgNiacin | 72 μg | 359 µgVitamin B6 | 8 μg | 42 µgFolic acid | 2.4 μg | 12 µgPantothenic acid | 96 μg | 478 µgVitamin B12 | 0.02 μg | 0.36 µgBiotin | 0.24 μg | 2.4 µgVitamin E | 0.14 mg α-TE | 1.2 mg α-TEVitamin K | 0.24 μg | 6 µgMineralsCalcium | 12 mg | 43 mgPhosphorus | 6 mg | 24 mgMagnesium | 1.2 mg | 3.6 mgIron | 0.24 mg | 0.48 mgIodine | 2.4 μg | 14 µgCopper | 8 μg | 29 µgZinc | 0.12 mg | 0.36 mgManganese | 0.24 μg | 24 μgSelenium | 0.48 μg | 2.2 µgElectrolytesChloride | 12 mg | 38 mgSodium | 4.8 mg | 14 mgPotassium | 14 mg | 43 mgNote It is recommended that follow-on formula contain a substance listed in Column 1 of the table in an amount that is not more than the amount (if any) specified for that substance in column 4 of the table. The amounts specified are Guidance Upper Levels and are recommended upper levels for nutrients which pose no significant risks on the basis of current scientific knowledge. These levels are values derived on the basis of meeting nutritional requirements of infants and an established history of apparent safe use. The Guidance Upper Levels should not be exceeded unless higher nutrient levels cannot be avoided due to high or variable contents in constituents of follow-on formula or due to technological reasons.S29—7 Optional nutritive substances in infant formula and special medical purpose product for infantsFor subsection 2.9.1—9(1) and section 2.9.1—37, the table is set out below.Optional nutritive substances in infant formula and special medical purpose product for infantsColumn 1 | Column 2 | Column 3Substance | Minimum amount per 100 kJ | Maximum amount per 100 kJ2′-fucosyllactose permitted for use by Standard 1.5.2 | 120 mg3-fucosyllactose permitted for use by Standard 1.5.2 | 80 mg3′-sialyllactose sodium salt permitted for use by Standard 1.5.2 | 11 mg6′-sialyllactose sodium salt permitted for use by Standard 1.5.2 | 28 mgA combination of 2′-fucosyllactose and difucosyllactose, permitted for use by Standard 1.5.2 | 96 mgA combination of: 2′-fucosyllactose permitted for use by Standard 1.5.2; and lacto-N-neotetraose permitted for use by Standard 1.5.2 | 120 mg which contains not more than 24 mg of lacto-N-neotetraoseAdenosine-5′-monophosphate | 0.36 mgCytidine-5′-monophosphate | 0.6 mgGuanosine-5′monophosphate | 0.4 mgInosine-5′-monophosphate | 0.24 mgLactoferrin | 40 mglacto-N-tetraose permitted for use by Standard 1.5.2 | 60 mgLutein | 1.5 µg | 5 µgMilk fat globule membrane-enriched whey protein concentrate | 0.14 g | 0.28 gTaurine | 2.9 mgUridine-5′-monophosphate | 0.42 mgS29—8 Optional nutritive substances in follow-on formulaFor subsection 2.9.1—9(2), the table is set out below.Optional nutritive substances in follow-on formulaColumn 1 | Column 2 | Column 3 | Column 4Substance | Minimum amount per 100 kJ | Maximum amount per 100 kJ | Guidance upper level per 100 kJ (see Note)2′-fucosyllactose permitted for use by Standard 1.5.2 | 120 mg3-fucosyllactose permitted for use by Standard 1.5.2 | 80 mg3′-sialyllactose sodium salt permitted for use by Standard 1.5.2 | 11 mg6′-sialyllactose sodium salt permitted for use by Standard 1.5.2 | 28 mgA combination of 2′-fucosyllactose and difucosyllactose, permitted for use by Standard 1.5.2 | 96 mgA combination of: 2′-fucosyllactose permitted for use by Standard 1.5.2; and lacto-N-neotetraose permitted for use by Standard 1.5.2 | 120 mg which contains not more than 24 mg of lacto-N-neotetraoseAdenosine-5′-monophosphate | 0.36 mgL-carnitine | 0.3 mgCholine | 12 mgCytidine-5′-monophosphate | 0.6 mgGuanosine-5′-monophosphate | 0.4 mgInosine-5′-monophosphate | 0.24 mgLactoferrin | 40 mglacto-N-tetraose permitted for use by Standard 1.5.2 | 60 mgLutein | 1.5 µg | 5 µgMilk fat globule membrane-enriched whey protein concentrate | 0.14 g | 0.28 gInositol | 10 mgTaurine | 2.9 mgUridine-5′-monophosphate | 0.42 mgNote It is recommended that follow-on formula contain a substance listed in Column 1 of the table in an amount that is not more than the amount (if any) specified for that substance in Column 4 of the table. The amounts specified in Column 4 are Guidance Upper Levels and are recommended upper levels for nutrients which pose no significant risks on the basis of current scientific knowledge. These levels are values derived on the basis of meeting nutritional requirements of infants and an established history of apparent safe use. The Guidance Upper Levels should not be exceeded unless higher nutrient levels cannot be avoided due to high or variable contents in constituents of follow-on formula or due to technological reasons.S29—9 Permitted forms of nutritive substances in infant formula products For paragraphs 2.9.1—10(b) and 2.9.1—38(b), the table is set out below.Permitted forms for nutritive substances used in infant formula productsSubstance | Permitted forms2′-fucosyllactose permitted for use by Standard 1.5.2 | 2′-fucosyllactose3-fucosyllactose permitted for use by Standard 1.5.2 | 3-fucosyllactose3′-sialyllactose sodium salt permitted for use by Standard 1.5.2 | 3′-sialyllactose sodium salt6'-sialyllactose sodium salt permitted for use by Standard 1.5.2 | 6'-sialyllactose sodium saltA combination of 2′-fucosyllactose and difucosyllactose, permitted for use by Standard 1.5.2 | 2'-fucosyllactose and difucosyllactoseA combination of: 2′-fucosyllactose permitted for use by Standard 1.5.2; and lacto-N-neotetraose permitted for use by Standard 1.5.2 | 2′-fucosyllactose and lacto-N-neotetraoseAdenosine-5′-monophosphate | Adenosine-5′- monophosphateL-carnitine | L-carnitineL-carnitine hydrochlorideL-carnitine tartrateCholine | Choline chlorideCholine bitartrateCholineCholine citrateCholine hydrogen tartrateCytidine-5′-monophosphate | Cytidine-5′-monophosphateGuanosine-5′-monophosphate | Guanosine-5′-monophosphateGuanosine-5′-monophosphate sodium saltInosine-5′-monophosphate | Inosine-5′-monophosphateInosine-5′-monophosphate sodium saltLactoferrin | Bovine lactoferrinlacto-N-tetraose permitted for use by Standard 1.5.2 | lacto-N-tetraoseLutein | Lutein from Tagetes erecta L.Milk fat globule membrane-enriched whey protein concentrate | Bovine milk fat globule membrane-enriched whey protein concentrateInositol | Myo-inositolTaurine | TaurineUridine-5′-monophosphate | Uridine-5′-monophosphate sodium saltNote Section S29—23 lists the permitted forms of vitamins, minerals and electrolytes in infant formula products.S29—9A Infant formula products—conditions on use of permitted nutritive substancesThe table for this section is as follows:Conditions of use for permitted nutritive substances Column 1 | Column 2 | Column 3Substance | Permitted Form | Conditions of useLactoferrin | Bovine lactoferrin | During the exclusive use period, may only be sold under the brand Synlait for *use as a nutritive substance in an infant formula product. For the purposes of condition 1 above, exclusive use period means the period commencing on the date of gazettal of the Food Standards (Application A1253 – Bovine Lactoferrin in Infant Formula Products) Variation and ending 15 months after that date.Milk fat globule membrane-enriched whey protein concentrateBovine milk fat globule membrane-enriched whey protein concentrate1. During the exclusive use period, may only be sold under the brand Lacprodan® MFGM-10 for *use as a nutritive substance in an infant formula product.2. For the purposes of condition 1 above, exclusive use period means the period commencing on the date of gazettal of the Food Standards (Application A1307 – Milk fat globule membrane as a nutritive substance in infant formula products) Variation and ending 15 months after that date.S29—10 Required format for a nutrition information statement The table to this section is:NUTRITION INFORMATIONAverage quantity per 100 mL prepared formulaEnergy | kJProtein | g— Whey* | g— Casein* | gFat | g— Long chain polyunsaturatedfatty acids*— Docosahexaenoic acid (DHA)* | mg— Eicosapentaenoic acid (EPA)* | mg— Arachidonic acid (ARA)* | mgCarbohydrate | gVitaminsVitamin A | μgVitamin B6 | μgVitamin B12 | μgVitamin C | mgVitamin D | μgVitamin E | mgVitamin K | μgBiotin | μgNiacin (B3) | μgFolate | μgPantothenic acid (B5) | μgRiboflavin (B2) | μgThiamin (B1) | μgMineralsCalcium | mgCopper | μgIodine | μgIron | mgMagnesium | mgManganese | μgPhosphorus | mgSelenium | μgZinc | mgChloride | mgPotassium | mgSodium | mgOther nutrients*Choline* | mgInositol* | mgL-carnitine* | mgAdditional(insert any other substance used as a nutritive substance; or inulin-type fructans and / or galacto-oligosaccharides, to be declared) | g, mg, μgNote: *See the following.Entries and amounts for the following need only be included when stated in accordance with subsection 2.9.1—24(4), 2.9.1—24(5) and paragraph 2.9.1—25(6)(d): whey; casein; docosahexaenoic acid; eicosapentaenoic acid; arachidonic acid.The heading ‘Other nutrients’ need only be included when required by subparagraph 2.9.1—25(2)(d)(ii) and paragraph 2.9.1—25(4)(a).The heading ‘Long chain polyunsaturated fatty acids’ need only be included when required by paragraph 2.9.1—25(6)(a).Entries and amounts for choline, inositol, L-carnitine are included under the heading ‘Other nutrients’ when required by paragraph 2.9.1—25(4)(a) and under the heading ‘Additional’ when required by paragraph 2.9.1—25(4)(b).S29—10A Example of a nutrition information statement including quantities expressed as sold For subsection 2.9.1—25(7), an example nutrition information statement including information expressed in accordance with subsection 2.9.1—24(7) is:NUTRITION INFORMATIONAverage quantity per 100 mL prepared formula | Quantity per 100 g powder (or 100 mL liquid concentrate)Energy | kJ | kJProtein | g | g— Whey | g | g— Casein | g | gFat | g | g— Long chain polyunsaturatedfatty acids— Docosahexaenoic acid (DHA) | mg | mg— Eicosapentaenoic acid (EPA) | mg | mg— Arachidonic acid (ARA) | mg | mgCarbohydrate | g | gVitaminsVitamin A | μg | μgVitamin B6 | μg | μgVitamin B12 | μg | μgVitamin C | mg | mgVitamin D | μg | μgVitamin E | mg | mgVitamin K | μg | μgBiotin | μg | μgNiacin (B3) | μg | μgFolate | μg | μgPantothenic acid (B5) | μg | μgRiboflavin (B2) | μg | μgThiamin (B1) | μg | μgMineralsCalcium | mg | mgCopper | μg | μgIodine | μg | μgIron | mg | mgMagnesium | mg | mgManganese | μg | μgPhosphorus | mg | mgSelenium | μg | μgZinc | mg | mgChloride | mg | mgPotassium | mg | mgSodium | mg | mgOther nutrientsCholine | mg | mgInositol | mg | mgL-carnitine | mg | mgAdditional(insert any other substance used as a nutritive substance; or inulin-type fructans and / or galacto-oligosaccharides, to be declared) | g, mg, μg | g, mg, μgS29—11 Food for infants—claims that can be made about vitamins and minerals added to cereal-based food for infantsFor section 2.9.2—10, the table is:Claims that can be made about vitamins and minerals added to cereal-based food for infantsVitamin or mineral | Maximum claim per serveThiamin (mg) | 15% RDINiacin (mg) | 15% RDIFolate (μg) | 10% RDIVitamin B6 (mg) | 10% RDIVitamin C (mg) | 10% RDIMagnesium (mg) | 15% RDIS29—12 Formulated meal replacements—vitamins and minerals that must be present in formulated meal replacements(1) For sections 2.9.3—3, 2.9.3—4 and 2.9.6—4, the table is set out below.(2) In the table, the amounts set out in columns 2 and 3 are for a 1-meal serving, and are expressed as a proportion of the RDI.Vitamins and minerals that must be present in formulated meal replacementsColumn 1 | Column 2 | Column 3Vitamin or mineral | Maximum amount | Maximum claimVitamin A | 300 μg (40%) | 300 μg (40%)Thiamin | No amount set | 0.55 mg (50%)Riboflavin | No amount set | 0.85 mg (50%)Niacin | No amount set | 5 mg (50%)Folate | No amount set | 100 μg (50%)Vitamin B6 | No amount set | 0.8 mg (50%)Vitamin B12 | No amount set | 1 μg (50%)Vitamin C | No amount set | 20 mg (50%)Vitamin D | 5.0 μg (50%) | 5 μg (50%)Vitamin E | No amount set | 5 mg (50%)Calcium | No amount set | 400 mg (50%)Iodine | 75 μg (50%) | 75 μg (50%)Iron | No amount set | 4.8 mg (40%)Magnesium | No amount set | 160 mg (50%)Phosphorus | No amount set | 500 mg (50%)Zinc | No amount set | 4.8 mg (40%)S29—13 Vitamins and minerals that may be added to formulated meal replacements(1) For sections 2.9.3—3, 2.9.3—4 and 2.9.6—4, the table is set out below.(2) In the table, the amounts set out in columns 2 and 3 are for a 1-meal serving, and are expressed as a proportion of the *ESADDI unless stated otherwise.Vitamins and minerals that may be added to formulated meal replacementsColumn 1 | Column 2 | Column 3Vitamin or mineral | Maximum amount | Maximum claimBiotin | No amount set | 5 μg (17%)Pantothenic acid | No amount set | 0.8 mg (17%)Vitamin K | No amount set | 40 μg (50%)Chromium:inorganic | 34 μg (17%) | 34 μg (17%)organic | 16 μg (8%) | no claim permittedCopper:inorganic | 0.50 mg (17%) | 0.50 mg (17%)organic | 0.24 mg (8%) | no claim permittedManganese:inorganic | 0.85 mg (17%) | 0.85 mg (17%)organic | 0.4 mg (8%) | no claim permittedMolybdenum:inorganic | 42.5 μg (17%) | 42.5 μg (17%)organic | 20 μg (8%) | no claim permittedSelenium:inorganic | 17.5 μg (25% RDI) | 17.5 μg (25% RDI)organic | 9 μg (13% RDI) | 9 μg (13% RDI)S29—14 Vitamins and minerals that may be added to formulated supplementary foods(1) For sections 2.9.3—5 and 2.9.3—6, the table is set out below.(2) In the table, the amounts set out in Columns 2 and 3 are for a serving, and are expressed as a proportion of the RDI.Vitamins and minerals that may be added to formulated supplementary foodsColumn 1 | Column 2 | Column 3Vitamin or mineral | Maximum amount | Maximum claimVitaminsVitamin A | 340 μg (45%) | 265 μg (35%)Thiamin | No amount set | 0.55 mg (50%)Riboflavin | No amount set | 0.85 mg (50%)Niacin | No amount set | 5 mg (50%)Folate | No amount set | 100 μg (50%)Vitamin B6 | No amount set | 0.8 mg (50%)Vitamin B12 | No amount set | 1 μg (50%)Vitamin C | No amount set | 20 mg (50%)Vitamin D | 5 μg (50%) | 5 μg (50%)Vitamin E | No amount set | 5 mg (50%)MineralsCalcium | No amount set | 400 mg (50%)Iodine | 75 μg (50%) | 75 μg (50%)Iron | No amount set | 6 mg (50%)Magnesium | No amount set | 130 mg (40%)Phosphorus | No amount set | 500 mg (50%)Zinc | No amount set | 3 mg (25%)S29—15 Vitamins and minerals that may be added to formulated supplementary food for young children(1) For sections 2.9.3—7 and 2.9.3—8, the table is set out below.(2) In the table, the amounts set out in Columns 2 and 3 are for a serving, and are expressed as a proportion of the RDI.Vitamins and minerals that may be added to formulated supplementary food for young childrenColumn 1 | Column 2 | Column 3Vitamin or mineral | Maximum amount (as percentage of RDI) | Maximum claim (as percentage of RDI)VitaminsVitamin A | 135 μg (45%) | 105 μg (35%)Thiamin | No amount set | 0.25 mg (50%)Riboflavin | No amount set | 0.4 mg (50%)Niacin | No amount set | 2.5 mg (50%)Folate | No amount set | 50 μg (50%)Vitamin B6 | No amount set | 0.35 mg (50%)Vitamin B12 | No amount set | 0.5 μg (50%)Vitamin C | No amount set | 15 mg (50%)Vitamin D | 2.5 μg (50%) | 2.5 μg (50%)Vitamin E | No amount set | 2.5 mg (50%)MineralsCalcium | No amount set | 350 mg (50%)Iodine | 70 μg (100%) | 35 μg (50%)Iron | No amount set | 3.0 mg (50%)Magnesium | No amount set | 32 mg (40%)Phosphorus | No amount set | 250 mg (50%)Zinc | No amount set | 1.1 mg (25%)S29—16 Vitamins and minerals that may be added to formulated supplementary sports foods(1) For section 2.9.4—3, the table is set out below.(2) In the table, the amounts set out in Columns 2 and 3 are for a *one-day quantity.Vitamins and minerals that may be added to formulated supplementary sports foodsColumn 1 | Column 2 | Column 3Vitamin or mineral | Maximum amount | Maximum claimVitaminsVitamin A | 375 μg | 375 μgThiamin | 2.2 mgRiboflavin | 3.4 mgNiacin | 20 mgFolate | 400 μgVitamin B6 | 3.2 mgVitamin B12 | 4 μgVitamin C | 80 mgVitamin D | 2.5 μg | 2.5 μgVitamin E | 20 mgBiotin | 50 μgPantothenic acid | 3.5 mgMineralsCalcium | 1 600 mgChromium:inorganic forms | 100 μg | 100 μgorganic forms | 50 μg | 50 μgCopper:inorganic forms | 1.5 mg | 1.5 mgorganic forms | 750 μg | 750 μgIodine | 75 μg | 75 μgIron | 12 mgMagnesium | 640 mgManganese:inorganic forms | 2.5 mgorganic forms | 1.25 mgMolybdenum:inorganic forms | 125 μgorganic forms | 62.5 μgPhosphorus | 1 000 mgSelenium:inorganic forms | 52 μg | 52 μgorganic forms | 26 μg | 26 μgZinc | 12 mgS29—17 Additional permitted forms for vitamins and minerals in formulated supplementary sports foods and in formulated meal replacementsFor sections 2.9.3—3 and 2.9.4—3, the table is:Additional permitted formsColumn 1 | Column 2Vitamin or mineral | Permitted formsBiotin | d-biotinPantothenic acid | d-sodium pantothenateCalcium | Calcium hydroxideChromium:inorganic forms | Chromic chlorideorganic forms | High chromium yeastChromium picolinateChromium nicotinateChromium aspartateCopper:inorganic forms | Cupric carbonateCupric sulphateorganic forms | Copper gluconateCopper-lysine complexCupric citrateMagnesium | Magnesium citrateMagnesium hydroxideManganese:inorganic forms | Manganese carbonateManganese chlorideManganese sulphateorganic forms | Manganese citrateMolybdenum:inorganic forms | Sodium molybdateorganic forms | High molybdenum yeastPhosphorus | Magnesium phosphate, monobasicPotassium phosphate, tribasicSodium phosphate, monobasicSodium phosphate, tribasicPhosphoric acidS29—18 Amino acids that may be added to formulated supplementary sports foodFor paragraph 2.9.4—3(1)(b), the table is.Amino acids that may be added to formulated supplementary sports foodColumn 1 | Column 2Amino acid | Maximum amount that may be added to a one-day quantityL-Alanine | 1 200 mgL-Arginine | 1 100 mgL-Aspartic acid | 600 mgL-Cysteine | 440 mgL-Glutamine | 1 900 mgL-Glutamic acid | 1 600 mgGlycine | 1 500 mgL-Histidine | 420 mgL-Isoleucine | 350 mgL-Leucine | 490 mgL-Lysine | 420 mgL-Methionine | 180 mgL-Ornithine | 360 mgL-Phenylalanine | 490 mgL-Proline | 1 100 mgL-Serine | 1 400 mgL-Taurine | 60 mgL-Threonine | 245 mgL-Tyrosine | 400 mgL-Tryptophan | 100 mgL-Valine | 350 mgS29—19 Substances that may be used as nutritive substances in formulated supplementary sports foodFor paragraph 2.9.4—3(1)(c), the table is:Substances that may be used as nutritive substances in formulated supplementary sports foodColumn 1 | Column 2Substance | Maximum amount that may be added to a one-day quantityL-carnitine | 2 gCholine | 10 mgInosine | 10 mgUbiquinones | 15 mgCreatine | 3 gGamma-oryzinol | 25 mgS29—20 Substances that may be added to food for special medical purposesFor section 2.9.5—6, the table is.Substances that may be added to food for special medical purposesColumn 1 | Column 2Substance | Permitted formsVitaminsNiacin | Nicotinamide riboside chlorideNicotinic acidVitamin B6 | Pyridoxine dipalmitateFolate | Calcium L-methylfolateVitamin E | D-alpha-tocopherolD-alpha-tocopheryl polyethylene glycol-1000 succinate (TPGS)Vitamin K | Vitamin K2 (as menaquinone-7)Pantothenic acid | Sodium pantothenateD-panthenolDL-panthenolMinerals and electrolytesBoron | Sodium borateBoric acidCalcium | Calcium bisglycinateCalcium citrate malateCalcium malateCalcium L-pidolateChloride | Choline chlorideSodium chloride, iodisedHydrochloric acidChromium | Chromium chlorideChromium picolinateChromium potassium sulphateCopper | Copper-lysine complexCupric carbonateFluoride | Potassium fluorideSodium fluorideIodine | Sodium iodateIron | Carbonyl ironElectrolytic ironFerric citrateFerric gluconateFerric orthophosphateFerric pyrophosphate, sodiumFerric saccharateFerric sodium diphosphateFerrous bisglycinateFerrous carbonateFerrous carbonate, stabilisedFerrous L-pidolateIron, reduced (ferrum reductum)Magnesium | Magnesium acetateMagnesium L-aspartateMagnesium bisglycinateMagnesium citrateMagnesium glycerophosphateMagnesium hydroxideMagnesium hydroxide carbonateMagnesium lactateMagnesium phosphate, monobasicMagnesium L-pidolateMagnesium potassium citrateManganese | Manganese glycerophosphateMolybdenum | Ammonium molybdatePotassium | Potassium glycerophosphatePotassium lactatePotassium L-pidolateSelenium | Selenium enriched yeastSodium hydrogen seleniteSodium selenateZinc | Zinc bisglycinateZinc carbonateZinc citrateZinc lactateOther substancesAmino acids | Sodium, potassium, calcium, magnesium salts of single amino acids listed in this sectionHydrochlorides of single amino acids listed in this sectionL-alanineL-arginineL-arginine acetateL-asparagineL-aspartic acidL-citrullineL-cysteineL-cystineL-glutamic acidL-glutamineGlycineL-histidineL-isoleucineL-leucineL-lysineL-lysine acetateL-methionineL-ornithineL-phenylalanineL-prolineL-serineL-threonineL-tyrosineL-tryptophanL-valineL-arginine-L-aspartateL-lysine-L-aspartateL-lysine-L-glutamateN-acetyl-L-methionineCarnitine | L-carnitineL-carnitine hydrochlorideL-carnitine L-tartrateCholine | CholineCholine bitartrateCholine chlorideCholine citrateCholine hydrogen tartrateInositol | InositolNucleotides | Adenosine-5′-monophosphateAdenosine-5′-monophosphate sodium saltCytidine-5′-monophosphateCytidine-5′-monophosphate sodium saltGuanosine-5′-monophosphateGuanosine-5′-monophosphate sodium saltInosine-5′-monophosphateInosine-5′-monophosphate sodium saltUridine-5′-monophosphateUridine-5′-monophosphate sodium saltTaurine | TaurineS29—21 Amounts of nutrients for food for special medical purposes represented as a sole source of nutritionFor section, 2.9.5—7, the table is:Amounts of nutrients for food for special medical purposes represented as a sole source of nutritionColumn 1 | Column 2 | Column 3Nutrient | Minimum amount per MJ | Maximum amount per MJVitaminsVitamin A | 84 µg retinol equivalents1 | 430 µg retinol equivalents1Thiamin | 0.15 mg | No maximum setRiboflavin | 0.2 mg | No maximum setNiacin | 2.2 mg niacin equivalents2 | No maximum setVitamin B6 | 0.2 mg | 1.2 mgFolate | 25 µg | No maximum setVitamin B12 | 0.17 µg | No maximum setVitamin C | 5.4 mg | No maximum setVitamin D(a) for products intended for children aged 1–10 years—1.2 µg7.5 µg(b) otherwise— | 1.2 µg | 6.5 µgVitamin E | 1 mg alpha-tocopherol equivalents3 | No maximum setBiotin | 1.8 µg | No maximum setPantothenic Acid | 0.35 mg | No maximum setVitamin K | 8.5 µg | No maximum setMineralsCalcium(a) for products intended for children aged 1–10 years— | 120 mg | 600 mg(b) otherwise— | 84 mg | 420 mgMagnesium | 18 mg | No maximum setIron | 1.2 mg | No maximum setPhosphorus | 72 mg | No maximum setZinc | 1.2 mg | 3.6 mgManganese | 0.12 mg | 1.2 mgCopper | 0.15 mg | 1.25 mgIodine | 15.5 µg | 84 µgChromium | 3 µg | No maximum setMolybdenum | 7 µg | No maximum setSelenium | 6 µg | 25 µgElectrolytesSodium | 72 mg | No maximum setPotassium | 190 mg | No maximum setChloride | 72 mg | No maximum setNote 1 See paragraph 1.1.2—14(3)(a).Note 2 For niacin, add niacin and any niacin provided from the conversion of the amino acid tryptophan, using the conversion factor 1:60.Note 3 See paragraph 1.1.2—14(3)(c).S29—22 Nutritional content requirements for a very low energy dietFor paragraph 2.9.5—18(1)(f), the table is:Amounts of nutrients in a very low energy dietColumn 1 | Column 2Nutrient | Minimum amount per daily intakeVitaminsVitamin A | 600 µg retinol equivalents1Vitamin D | 2.5 µgVitamin E | 10 mg α-tocopherol equivalents2Vitamin C | 30 mgVitamin B6 | 2 mgVitamin B12 | 1 µgNiacin | 11 mg niacin equivalents3Riboflavin | 1.2 mgThiamin | 0.8 mgFolic Acid | 200 µgMineralsCalcium | 500 mgPhosphorus | 500 mgIron | 16 mgIodine | 140 µgMagnesium | 350 mgCopper | 1.5 mgZinc | 6 mgPotassium | 1.6 gSodium | 1 gNote 1 See paragraph 1.1.2—14(3)(a).Note 2 See paragraph 1.1.2—14(3)(c).Note 3 For niacin, add niacin and any niacin provided from the conversion of the amino acid tryptophan, using the conversion factor 1:60.S29—23 Permitted forms of vitamins, minerals and electrolytes in infant formula products, food for infants, formulated meal replacements (vitamin K) and food for special medical purposesFor sections 2.9.1—10(a), 2.9.1—38(a), 2.9.2—4, 2.9.2—5, 2.9.2—6, 2.9.3—3(2)(c)(iii) and 2.9.5—6, the table is:Permitted forms of vitamins, minerals and electrolytes in infant formula products, food for infants, formulated meal replacements (vitamin K) and food for special medical purposesVitamin, mineral or electrolyte | Permitted formsVitamin ARetinol forms | vitamin A (retinol)vitamin A acetate (retinyl acetate)vitamin A palmitate (retinyl palmitate)retinyl propionateProvitamin A forms | beta-caroteneVitamin C | L-ascorbic acidL-ascorbyl palmitatecalcium ascorbatepotassium ascorbatesodium ascorbateVitamin D | vitamin D2 (ergocalciferol)vitamin D3 (cholecalciferol)vitamin D (cholecalciferol-cholesterol)Thiamin | thiamin hydrochloridethiamin mononitrateRiboflavin | riboflavinriboflavin-5′-phosphate, sodiumNiacin | niacinamide (nicotinamide)Vitamin B6 | pyridoxine hydrochloridepyridoxine-5′-phosphateFolate | Folic acidPantothenic acid | calcium pantothenatedexpanthenolD-panthenolcalcium D-pantothenatesodium D-pantothenateVitamin B12 | cyanocobalaminhydroxocobalaminBiotin | d-biotinVitamin E | dl-α-tocopherold-α-tocopherol concentratetocopherols concentrate, mixedd-α-tocopheryl acetatedl-α-tocopheryl acetated-α-tocopheryl acid succinatedl-α-tocopheryl succinateVitamin K | Vitamin K1 as phylloquinone (phytonadione)Calcium | calcium carbonatecalcium chloridecalcium citratecalcium gluconatecalcium glycerophosphatecalcium hydroxidecalcium lactatecalcium oxidecalcium phosphate, dibasiccalcium phosphate, monobasiccalcium phosphate, tribasiccalcium sulphateChloride | calcium chloridemagnesium chloridepotassium chloridesodium chlorideChromium | chromium sulphateCopper | copper gluconatecupric sulphatecupric citratecupric carbonateIodine | potassium iodatepotassium iodidesodium iodideIron | ferric ammonium citrateferric citrateferric pyrophosphateferrous bisglycinateferrous citrateferrous fumarateferrous gluconateferrous lactateferrous succinateferrous sulphateMagnesium | magnesium carbonatemagnesium chloridemagnesium gluconatemagnesium oxidemagnesium phosphate, dibasicmagnesium phosphate, tribasicmagnesium sulphatemagnesium hydroxide carbonatemagnesium hydroxidemagnesium salts of citric acidManganese | manganese carbonatemanganese chloridemanganese citratemanganese gluconatemanganese sulphateMolybdenum | sodium molybdate VIPhosphorus | calcium glycerophosphatecalcium phosphate, dibasiccalcium phosphate, monobasiccalcium phosphate, tribasicmagnesium phosphate, dibasicpotassium phosphate, dibasicpotassium phosphate, monobasicpotassium phosphate, tribasicsodium phosphate, dibasicsodium phosphate, monobasicsodium phosphate, tribasicPotassium | potassium bicarbonatepotassium carbonatepotassium chloridepotassium citratepotassium glycerophosphatepotassium gluconatepotassium hydroxidepotassium phosphate, dibasicpotassium phosphate, monobasicpotassium phosphate, tribasicpotassium L-lactateSelenium | seleno methioninesodium selenatesodium seleniteSodium | sodium bicarbonatesodium carbonatesodium chloridesodium chloride iodisedsodium citratesodium gluconatesodium hydroxidesodium iodidesodium lactatesodium phosphate, dibasicsodium phosphate, monobasicsodium phosphate, tribasicsodium sulphatesodium tartrateZinc | zinc acetatezinc chloridezinc citrate (zinc citrate dihydrate or zinc citrate trihydrate)zinc gluconatezinc lactatezinc oxidezinc sulphateApplication, saving and transitional provisionsThe table below details information on application, saving or transitional provisions in instruments affecting this Standard.Instrument items affectedA’ment No.FRLI registrationGazetteInstrument’s transitional provisionDescription of transitional arrangementFood Standards (Application A1230 – Very Low Energy Diets (VLED)) VariationItem [4.1] of the Schedule208F2022L007331 June 2022FSC 1481 June 2022Clause 4Clause 4 of the Food Standards (Application A1230 – Very Low Energy Diets (VLED)) Variation provides a transitional arrangement for the variations to the Code made by Item [4.1] of the Schedule to that legislative instrument.Subclause 4(1) provides that section 1.1.1—9 of the Code does not apply to the variations made by that instrument.Subclause 4(2) provides that, during the transition period, a food product may be sold if the product complies with one of the following:the Code as in force without the variations made by the instrument;the Code as amended by the variations made by the instrument.Subclause 4(3) provides that, for the purposes of the above, the transition period is the period commencing on the variation’s date of commencement and ending 36 months after the date of commencement.This means that the transition period is the period of time that commences on 1 June 2022 and ends on 1 June 2025.Food Standards (Proposal P1028 – Infant Formula Products – Consequential Amendments) VariationItems [1] and [2] of Schedule 1231F2024L0115113 Sept 2024FSC 17113 Sept 2024Clause 4Clause 4 establishes a transitional arrangement for variations to the Code made by Items [1] and [2] of Schedule 1 and by the Food Standards (Proposal P1028 – Infant Formula Products – Consequential Amendments) Variation.The transition period is the period of time that commences on 13 September 2024 and ends on 13 September 2029.Subclause 4(1) provides that section 1.1.1—9 of the Code does not apply to the variations.Subclause 4(2) provides that during the transition period a food product may be sold if the product complies with one of the following:(a) the Code as in force without the above variations;(b) the Code as amended by the above variations.Amendment HistoryThe Amendment History provides information about each amendment to the Schedule. The information includes commencement or cessation information for relevant amendments.These amendments are made under section 92 of the Food Standards Australia New Zealand Act 1991 unless otherwise indicated. Amendments do not have a specific date for cessation unless indicated as such.About this compilationThis is compilation No. 19 of Schedule 29 as in force on 1 September 2026 (up to Amendment No. 252). It includes any commenced amendment affecting the compilation to that date.Prepared by Food Standards Australia New Zealand on 1 September 2026.Uncommenced amendments or provisions ceasing to have effect.To assist stakeholders, the effect of any uncommenced amendments or provisions which will cease to have effect, may be reflected in the Schedule as shaded boxed text with the relevant commencement or cessation date. These amendments will be reflected in a compilation registered on the Federal Register of Legislation including or omitting those amendments and provided in the Amendment History once the date is passed.The following abbreviations may be used in the table below:ad = added or inserted am = amendedexp = expired or ceased to have effect rep = repealedrs = repealed and substitutedSchedule 29 was published in the Food Standards Gazette No. FSC96 on 10 April 2015 as part of Amendment 154 (F2015L00463 –- 1 April 2015) and has since been amended as follows:Section affectedA’ment No.FRL registrationGazetteCommencement(Cessation)How affectedDescription of amendmentS29—7172F2017L011426 Sept 2017FSC1147 Sept 20177 Sept 2017amOmit ‘phytylmenoquinone’ from table.S29—10(3)157F2015L013741 Sept 2015FSC993 Sept 20151 March 2016rsSubsection and related table.S29—17161F2016L0012018 Feb 2016FSC10322 Feb 20161 March 2016amCorrection of typographical error in table heading.S29—20168F2017L0041411 April 2017FSC11013 April 201713 April 2017amInsertion of a sodium fluoride as a permitted form of fluoride which was inadvertently omitted in FSC96.S29—20173F2017L0117613 Sept 2017FSANZ Notification Circular 24-17 (Urgent Proposal)14 Sept 201714 Sept 2017amOmit L-arginine and substituting L-arginine and L-arginine acetate as a permitted form of Amino acids.S29—21161F2016L0012018 Feb 2016FSC10322 Feb 20161 March 2016rsNotes 1, 2 and 3 to correct incorrect cross-reference and missing full stops.S29—21168F2017L0041411 April 2017FSC11013 April 201713 April 2017amCorrection to abbreviation of megajoule in the heading,Correction to formatting error for entry for vitamin E.S29—14182F2018L0159423 Nov 2018FSC12329 Nov 201829 Nov 2018amCorrections to typographical error (1)S29—14186F2019L0099617 July 2019FSC12725 July 201925 July 2019amOmit L-carnitine 100mg and substitute L-carnitine 2gS29—5198F2021L0033225 March 2021FSC13926 March 202126 March 2021amInserting 2′-O-fucosyllactose and lacto-N-neotetraoseS29—7200F2021L006842 June 2021FSC1413 June 20213 June 2021amCorrection of typographical error in table heading.S29—20203F2021L0143114 October 2021FSC14421 October 202121 October 2021amOmit nicotinic acid and substitute Nicotinamide riboside chloride and nicotinic acid2.9.1—5205F2022L0003818 Jan 2022FSC14620 Jan 202220 January 2022rsOmit 2′-O-fucosyllactose and substitute 2′-fucosyllactoseS29—22208F2022L007331 June 2022FSC 1481 June 20221 June 2022adAdded section 22For application, saving and transitional provisions, see above table.S29—5217F2023L0045219 April 2023FSC15721 April 202321 April 2023adInsert entry for lactoferrin – bovine lactoferrin.S29—5A217F2023L0045219 April 2023FSC15721 April 202321 April 2023adInsert section S29—5AS29—5223F2023L0156127 Nov 2023FSC16330 Nov 202330 Nov 2023adInsert in table to S29—5 entries for the following substances:3'-sialyllactose sodium salt,6'-sialyllactose sodium salt,a combination of 2′-fucosyllactose with difucosyllactose, andlacto-N-tetraoseS29—2 through to S29—10231F2024L0115113 Sept 2024FSC17113 Sept 202413 Sept 2024rsRepeal sections S29—2 to S29—10 and substitute with new S29—2 to S29—10AS29—23231F2024L0115113 Sept 2024FSC17113 Sept 202413 Sept 2024adInsert after section s29—22 new section entry S29—23S29—20235F2025L0016320 Feb 2025FSC 17520 Feb 202520 February 2025adInsert new entry for vitamin KS29—7 through to S29-9A240F2025L0085722 July 2025FSC 18022 July 202522 July 2025adInsert to tables S29—7, S29—8, S29—9 and S29—9A new entry for milk fat globule membrane-enriched whey protein concentrateS29—7, S29—8 & S29—9247F2026L0002215 January 2026FSC 18720 January 202620 January 2026amInsert to tables new entry for 3-fucosyllactose permitted for use by Standard 1.5.2S29—19249F2026L0048130 April 2026FSC 18930 April 202630 April 2026amTypographical correction was made to the weight unit in the entry for L-carnitineS29—7 & S29—8252F2026L0112728 August 2026FSC 1921 Sep 20261 September 2026amRepeal and substitute the Maximum amount per 100 kJ values in Column 3 for 2′-fucosyllactose, 3′-sialyllactose, 6′-sialyllactose, and lacto-N-tetraoseS29—7 & S29—8252F2026L0112728 August 2026FSC 1921 Sep 20261 September 2026amRepeal and substitute the Maximum amount per 100 kJ values in Column 3 for 2′-fucosyllactose, for the entry “A combination of: 2′-fucosyllactose permitted for use by Standard 1.5.2; and lacto-N-neotetraose permitted for use by Standard 1.5.2”